HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyun Don Yun Selected Research

dinaciclib

1/2019Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyun Don Yun Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2019 - 01/2019
1Neoplasms (Cancer)
08/2023
1Peripheral Nervous System Diseases (PNS Diseases)
08/2023
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1Systemic Mastocytosis
01/2020
1B-Cell Prolymphocytic Leukemia
07/2013

Drug/Important Bio-Agent (IBA)

1CytokinesIBA
08/2023
1Interleukin-6 (Interleukin 6)IBA
08/2023
1gilteritinibIBA
11/2019
1dinaciclibIBA
01/2019
1Pentostatin (Nipent)FDA LinkGeneric
07/2013

Therapy/Procedure

1Drug Therapy (Chemotherapy)
08/2023
1Therapeutics
01/2020